OFREMKO

Serial Number 86944921
606

Registration Progress

Application Filed
Mar 18, 2016
Under Examination
Oct 4, 2016
Approved for Publication
Aug 9, 2016
Published for Opposition
Aug 9, 2016
Registered

Basic Information

Serial Number
86944921
Filing Date
March 18, 2016
Published for Opposition
August 9, 2016
Abandonment Date
November 4, 2019
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Nov 4, 2019
Classes
005

Rights Holder

Alnylam Pharmaceuticals, Inc.

03
Address
300 Third Street
Cambridge, MA 02142

Quick Actions

Search by Rights Holder Search by Attorney Search by Status Code 606

Ownership History

Alnylam Pharmaceuticals, Inc.

Original Applicant
03
Cambridge, MA

Alnylam Pharmaceuticals, Inc.

Owner at Publication
03
Cambridge, MA

Legal Representation

Attorney
Timothy H. Hiebert

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

31 events
Date Code Type Description
Nov 4, 2019 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
Nov 4, 2019 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Apr 4, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 3, 2019 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 3, 2019 EX5G S SOU EXTENSION 5 GRANTED
Mar 28, 2019 EEXT I SOU TEAS EXTENSION RECEIVED
Mar 28, 2019 EXT5 S SOU EXTENSION 5 FILED
Oct 5, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 3, 2018 EEXT I SOU TEAS EXTENSION RECEIVED
Oct 3, 2018 EXT4 S SOU EXTENSION 4 FILED
Oct 3, 2018 EX4G S SOU EXTENSION 4 GRANTED
Mar 16, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 14, 2018 EEXT I SOU TEAS EXTENSION RECEIVED
Mar 14, 2018 EXT3 S SOU EXTENSION 3 FILED
Mar 14, 2018 EX3G S SOU EXTENSION 3 GRANTED
Sep 29, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 27, 2017 EEXT I SOU TEAS EXTENSION RECEIVED
Sep 27, 2017 EXT2 S SOU EXTENSION 2 FILED
Sep 27, 2017 EX2G S SOU EXTENSION 2 GRANTED
Mar 17, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 15, 2017 EEXT I SOU TEAS EXTENSION RECEIVED
Mar 15, 2017 EXT1 S SOU EXTENSION 1 FILED
Mar 15, 2017 EX1G S SOU EXTENSION 1 GRANTED
Oct 4, 2016 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 9, 2016 PUBO A PUBLISHED FOR OPPOSITION
Aug 9, 2016 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 20, 2016 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 6, 2016 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 29, 2016 DOCK D ASSIGNED TO EXAMINER
Mar 23, 2016 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 22, 2016 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of transthyretin-mediated amyloidosis; Pharmaceutical preparations for the treatment of familial amyloidotic polyneuropathy
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005